Key points are not available for this paper at this time.
In patients with stage 4 or 5 chronic kidney disease or end-stage renal disease who received gadolinium-based contrast agents since 2010, diagnostic codes for potential nephrogenic systemic fibrosis or mimics were exceedingly rare.
Mallepally et al. (Mon,) studied this question.